Morning Brief anchor Julie Hyman breaks down the latest market news for August 18, 2025.
Novo Nordisk’s weight loss drug Wegovy is the first GLP-1 drug approved to treat liver disease. Senior health reporter Anjalee Khemlani breaks down the details.
Second-quarter earnings have proven to be strong.
According to Goldman Sachs, over 60% of S&P companies have beaten EPS forecasts. We look at what’s driving strong earnings for the second quarter, the strength of the economy, and the AI trade.
For more episodes of Morning Brief, please visit: https://finance.yahoo.com/videos/series/morning-brief/
#youtube #stocks #investing #glp1
About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
– Get the latest news and data at finance.yahoo.com
– Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)
– Follow Yahoo Finance on social:
X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/company/yahoo-finance
source
